Chatterjee Daipayan, Swamy Mathad K S, Gupta Vikas, Sharma Vasu, Sharma Akshat, Chatterjee Krishti
Vardhaman Mahavir Medical College, Department of Orthopedics, New Delhi, India Phone: 9007930192 E-mail:
J Clin Res Pediatr Endocrinol. 2017 Mar 1;9(1):63-69. doi: 10.4274/jcrpe.3557. Epub 2016 Aug 23.
Stosstherapy has been used since early 19 century for treating nutritional rickets. However, there are no clear cut guidelines for the biochemical monitoring of this treatment. Repeated blood tests at short intervals increase the cost of therapy and noncompliance.
A prospective study was conducted on 191 cases of nutritional rickets below 10 years of age to evaluate the effectivity of stosstherapy. All cases were treated with a single intramuscular injection of vitamin D (600.000 IU) along with oral calcium (50 mg/kg) and vitamin D (400 IU per day) until radiological resolution. Dietary modifications and adequate sunlight exposure were also recommended.
The mean age of presentation was 2 years 9 months. Mean sunlight exposure was 17 minutes/week with 90% having low sunlight exposure (<30 minutes/week). Prolonged breast feeding (>6 months) was found in 93.7% of the cases. With treatment, the clinical features started resolving by 1 month with complete resolution of most of the features over a period of 1 year. By 6 months, all the study subjects had complete radiological resolution. Serum levels of calcium and alkaline phosphatase (ALP) were restored by 6 months in most cases while phosphate and vitamin D levels normalized by 6 weeks.
Stosstherapy is a safe, cheap and effective method of treating nutritional rickets. Biochemical tests at initial presentation followed by vitamin D assay at 6 weeks and calcium, phosphate and ALP assays at 6 months is recommended in the monitoring of these patients. For regular monitoring, only ALP assay is recommended, provided one abstains from repeat injection of vitamin D based on high ALP levels.
自19世纪初以来,冲击疗法一直用于治疗营养性佝偻病。然而,对于该治疗的生化监测尚无明确的指导方针。短时间内反复进行血液检测会增加治疗成本且患者依从性差。
对191例10岁以下营养性佝偻病患儿进行前瞻性研究,以评估冲击疗法的有效性。所有病例均接受单次肌肉注射维生素D(600,000 IU),同时口服钙剂(50 mg/kg)和维生素D(每日400 IU),直至放射学表现恢复正常。还建议进行饮食调整并保证充足的日照。
患儿的平均就诊年龄为2岁9个月。平均日照时间为每周17分钟,90%的患儿日照时间较短(<每周30分钟)。93.7%的病例存在长期母乳喂养(>6个月)。经过治疗,临床症状在1个月时开始缓解,大多数症状在1年内完全缓解。到6个月时,所有研究对象的放射学表现均完全恢复正常。大多数病例在6个月时血清钙和碱性磷酸酶(ALP)水平恢复正常,而磷酸盐和维生素D水平在6周时恢复正常。
冲击疗法是治疗营养性佝偻病的一种安全、廉价且有效的方法。建议在这些患者的监测中,初诊时进行生化检测,随后在6周时检测维生素D,在6个月时检测钙、磷酸盐和ALP。对于定期监测,仅建议检测ALP,前提是不基于高ALP水平重复注射维生素D。